Latest News & Updates

Breaking News

1 day ago
Simantini Singh Deo

Merck KGaA, Darmstadt Germany to Acquire SpringWorks Therapeutics to Accelerate Healthcare Growth

Actimed Therapeutics Names Shaun Claydon As New Chief Financial Officer

Simantini Singh Deo

Plus Therapeutics Appoints Kyle Guse To Board Of Directors, Will Lead Audit Committee

Vaibhavi M.

Coave Therapeutics Strengthens U.S. Presence with Strategic Appointment of Romain Pettenaro as VP of Business Development

Simantini Singh Deo

Gannet BioChem Appoints Dr. Harry Rathore As New Board Member To Strengthen Leadership

Simantini Singh Deo

Other trending news you may like to read

Zentalis Begins Part 2 of DENALI Study Doses First Patient In Trial For Cyclin E1+ PROC With Azenosertib

Zentalis Pharmaceuticals begins dosing in DENALI Part 2 trial of azenosertib, targeting Cyclin E1+ PROC, aiming for accelerated approval if successful.

Simantini Singh Deo

Portage Biotech Announces Positive PORT-7 Data at AACR, Prepares for First-in-Human Trial

Portage Biotech shares promising PORT-7 preclinical results, eyes human trials and plans PORT-6, PORT-7 combo for enhanced immunotherapy.

Simantini Singh Deo

BridgeBio’s BEYONTTRA (Acoramidis) Approved In The UK for ATTR-CM, Marking A Major Advance In Cardiomyopathy Care.

BEYONTTRA® (acoramidis) approved in the UK for ATTR-CM, offering near-complete TTR stabilization and improved patient outcomes, based on Phase 3 study success.

Simantini Singh Deo

Beyond Air Awarded U.S. Patent For gNO Treatment Of NTM Infections, Paving The Way For New Therapies

Beyond Air secures U.S. Patent for using gNO to treat NTM lung infections, offering a new treatment option for patients.

Simantini Singh Deo